HLTH.L vs. BTEE.L
HLTH.L (SPDR® MSCI Europe Health Care UCITS ETF) and BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) are both Health & Biotech Equities funds - HLTH.L tracks the MSCI World/Health Care NR USD while BTEE.L tracks the NASDAQ Biotechnology TR USD. Both are passively managed. Over the past 5 years, HLTH.L returned 5.77%/yr vs 5.68%/yr for BTEE.L. A 0.55 correlation means they provide meaningful diversification when combined. HLTH.L charges 0.18%/yr vs 0.35%/yr for BTEE.L.
Performance
HLTH.L vs. BTEE.L - Performance Comparison
Loading charts...
Different Trading Currencies
HLTH.L is traded in EUR, while BTEE.L is traded in USD. To make them comparable, the BTEE.L values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, HLTH.L achieves a -1.46% return, which is significantly lower than BTEE.L's 5.77% return.
HLTH.L
- 1D
- 3.12%
- 1M
- 1.53%
- YTD
- -1.46%
- 6M
- -0.41%
- 1Y
- 6.14%
- 3Y*
- 2.79%
- 5Y*
- 5.77%
- 10Y*
- 6.14%
BTEE.L
- 1D
- 3.16%
- 1M
- 1.84%
- YTD
- 5.77%
- 6M
- 3.45%
- 1Y
- 39.07%
- 3Y*
- 10.11%
- 5Y*
- 5.68%
- 10Y*
- —
HLTH.L vs. BTEE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
HLTH.L SPDR® MSCI Europe Health Care UCITS ETF | -1.46% | 7.01% | 4.14% | 7.61% | -3.78% | 25.28% | -1.76% | 30.59% | 4.56% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 5.77% | 17.06% | 4.80% | 2.67% | -6.42% | 6.87% | 17.04% | 28.40% | -8.54% |
Correlation
The correlation between HLTH.L and BTEE.L is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.59 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.51 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Mar 9, 2018 | 0.55 |
The correlation between HLTH.L and BTEE.L has been stable across timeframes, ranging from 0.51 to 0.59 - a consistent structural relationship.
HLTH.L vs. BTEE.L - Sectors Allocation Comparison
Sectors
HLTH.L
BTEE.L
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
HLTH.L
BTEE.L
Basic Materials
HLTH.L
-
BTEE.L
-
Communication Services
HLTH.L
-
BTEE.L
-
Consumer Cyclical
HLTH.L
-
BTEE.L
-
Consumer Defensive
HLTH.L
-
BTEE.L
-
Energy
HLTH.L
-
BTEE.L
-
Financial Services
HLTH.L
-
BTEE.L
-
Industrials
HLTH.L
-
BTEE.L
-
Real Estate
HLTH.L
-
BTEE.L
-
Technology
HLTH.L
-
BTEE.L
-
Utilities
HLTH.L
-
BTEE.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HLTH.L vs. BTEE.L — Risk / Return Rank
HLTH.L
BTEE.L
HLTH.L vs. BTEE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR® MSCI Europe Health Care UCITS ETF (HLTH.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HLTH.L | BTEE.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.62 | ||
| Sortino ratioReturn per unit of downside risk | -2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 1.33 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | 0.49 | 6.02 | -5.54 |
| Martin ratioReturn relative to average drawdown | 1.07 | 16.49 | -15.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HLTH.L | BTEE.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | 1.99 | -1.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.37 | 0.27 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.34 | +0.02 |
Drawdowns
HLTH.L vs. BTEE.L - Drawdown Comparison
The maximum HLTH.L drawdown since its inception was -26.57%, smaller than the maximum BTEE.L drawdown of -31.23%. Use the drawdown chart below to compare losses from any high point for HLTH.L and BTEE.L.
Loading charts...
Drawdown Indicators
| HLTH.L | BTEE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -26.57% | -31.23% | +4.66% |
Max Drawdown (1Y)Largest decline over 1 year | -12.57% | -6.45% | -6.12% |
Max Drawdown (3Y)Largest decline over 3 years | -26.57% | -28.71% | +2.14% |
Max Drawdown (5Y)Largest decline over 5 years | -26.57% | -31.23% | +4.66% |
Max Drawdown (10Y)Largest decline over 10 years | -26.57% | — | — |
Current DrawdownCurrent decline from peak | -10.88% | -1.20% | -9.68% |
Average DrawdownAverage peak-to-trough decline | -9.38% | -10.19% | +0.81% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.71% | 2.36% | +3.35% |
Volatility
HLTH.L vs. BTEE.L - Volatility Comparison
The current volatility for SPDR® MSCI Europe Health Care UCITS ETF (HLTH.L) is 5.58%, while iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a volatility of 6.64%. This indicates that HLTH.L experiences smaller price fluctuations and is considered to be less risky than BTEE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HLTH.L | BTEE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.58% | 6.64% | -1.06% |
Volatility (6M)Calculated over the trailing 6-month period | 11.64% | 14.70% | -3.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.68% | 19.53% | -2.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.59% | 20.87% | -5.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.69% | 22.45% | -6.76% |
HLTH.L vs. BTEE.L - Expense Ratio Comparison
HLTH.L has a 0.18% expense ratio, which is lower than BTEE.L's 0.35% expense ratio.
Dividends
HLTH.L vs. BTEE.L - Dividend Comparison
HLTH.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.36%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.36% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
HLTH.L SPDR® MSCI Europe Health Care UCITS ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HLTH.L and BTEE.L have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, HLTH.L is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
HLTH.L is cheaper with a 0.18% expense ratio, compared with 0.35% for BTEE.L.
HLTH.L tracks MSCI World/Health Care NR USD, while BTEE.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: State Street and iShares. Their fees differ too: 0.18% for HLTH.L and 0.35% for BTEE.L.
Find the right allocation for HLTH.L and BTEE.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer